Proteomics

Dataset Information

0

Keap1 is an endogenous dCas9 suppressor inhibiting CRISPRa and CRISPRi efficiency


ABSTRACT: As a potent and accurate genome-editing tool, CRISPR-Cas9 has been widely used in biomedical research and evaluated as gene therapy in treating human diseases. Although distinct engineered Cas9s, dCas9s and additional endonucleases have been identified, as these bacterial enzymes do not naturally express in mammalian cells, whether and how bacterial Cas9 proteins are regulated by mammalian hosts remains poorly understood. Here, we identified Keap1 as an endogenous E3 ligase that targets Cas9/dCas9/Fanzor1 for ubiquitination and degradation. Cas9-“ETGE” mutants evading Keap1 recognition displayed enhanced gene editing ability in cells. dCas9-“ETGE” mutants displayed extended protein half-life on chromatin, leading to significantly improved CRISPa and CRISPRi efficacy. Cas9 binding to Keap1 also inactivate Keap1 function via competing with Keap1 substrates or binding partners, while engineered Cas9 mutants showed less perturbation. Thus, our study reveals a mammalian specific Cas9 regulation and provides new Cas9 designs not only with enhanced gene regulatory capacity but also with minimal effects on disrupting endogenous Keap1 signaling.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Permanent Cell Line Cell

SUBMITTER: Dennis Goldfarb  

LAB HEAD: Pengda Liu

PROVIDER: PXD050935 | Pride | 2025-01-20

REPOSITORIES: pride

Similar Datasets

2014-05-18 | E-GEOD-55887 | biostudies-arrayexpress
2021-11-23 | E-MTAB-10525 | biostudies-arrayexpress
2014-04-20 | E-GEOD-54745 | biostudies-arrayexpress
2018-03-12 | GSE87757 | GEO
2014-08-29 | E-GEOD-57650 | biostudies-arrayexpress
2017-10-12 | PXD003929 | Pride
2021-11-23 | E-MTAB-10523 | biostudies-arrayexpress
2016-09-23 | GSE83890 | GEO
2018-11-07 | PXD008411 | Pride
2015-03-04 | E-GEOD-61099 | biostudies-arrayexpress